Temat: "Antiretroviral Therapy, Highly Active" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Prevalence and predictors of virological failure in pediatric patients on HAART in sub-Saharan Africa: a systematic review and meta-analysis.
Autorzy:: Machila N; Department of Disease Control and Prevention, School of Medicine, Eden University, Lusaka, Zambia.
Libonda L; Department of Disease Control and Prevention, School of Medicine, Eden University, Lusaka, Zambia.
Habineza P; Department of Disease Control and Prevention, School of Medicine, Eden University, Lusaka, Zambia.
Velu RM; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Kamboyi HK; Department of Disease Control and Prevention, School of Medicine, Eden University, Lusaka, Zambia.; Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Hokkaido, Japan.
Ndhlovu J; Department of Disease Control and Prevention, School of Medicine, Eden University, Lusaka, Zambia.
Wamunyima I; Department of Disease Control and Prevention, School of Medicine, Eden University, Lusaka, Zambia.
Sinadambwe MM; Department of Women and Newborn, University Teaching Hospital, Lusaka, Zambia.
Mudenda S; Department of Pharmacy, School of Medicine, University of Zambia, Lusaka, Zambia.
Zyambo C; Department of Community and Family Health, School of Public Health, University of Zambia, Lusaka, Zambia.
Bumbangi FN; Department of Disease Control and Prevention, School of Medicine, Eden University, Lusaka, Zambia.; Pokaż więcej
Źródło:: The Pan African medical journal [Pan Afr Med J] 2023 Jun 22; Vol. 45, pp. 98. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Infectious Disease Transmission, Vertical*
Humans ; Child ; Female ; Prevalence ; Anti-Retroviral Agents ; Africa South of the Sahara/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Treatment failure and associated factors among people living with HIV on highly active antiretroviral therapy in mainland China: A systematic review and meta-analysis.
Autorzy:: Niu D; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Tang H; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chen F; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao D; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao H; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Hou Y; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang S; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Lyu F; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 May 02; Vol. 18 (5), pp. e0284405. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/complications
Humans ; Aged ; Adult ; Cross-Sectional Studies ; Tenofovir/therapeutic use ; Treatment Failure ; China/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
Autorzy:: Kahabuka MS; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia. .; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania. .
Woldeamanuel Y; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Mbelele PM; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.
Mpolya EA; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.; Institute for Health Metrics and Evaluation, Population Health Building/Hans Rosling Center, University of Washington, 3980 15th Avenue, 98195, Seattle, WA, USA.
Mpagama SG; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
Kessy JP; Mawenzi Regional Referral Hospital, Kilimanjaro, Tanzania.
Manyazewal T; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Apr 11; Vol. 24 (1), pp. 390. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Male ; Retrospective Studies ; Antiretroviral Therapy, Highly Active ; Tanzania/epidemiology ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.
Autorzy:: Darge T; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia. .
Babusha A; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Chilo D; Department of Pharmacy, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Dukessa A; Department of Biomedical Sciences, Institution of Health, Jimma University, Jimma, Ethiopia.
Teferi S; Department of Medical Laboratory Science, College of Health Sciences, Mettu University, Mettu, Ethiopia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 11; Vol. 14 (1), pp. 8473. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Coinfection*
Hepatitis C*/drug therapy
Liver Diseases*/etiology
Tuberculosis*/drug therapy
Drug-Related Side Effects and Adverse Reactions*/etiology
Digestive System Diseases*/drug therapy
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/etiology
Chemical and Drug Induced Liver Injury*/drug therapy
Adult ; Humans ; Antiretroviral Therapy, Highly Active/adverse effects ; Ethiopia/epidemiology ; Cross-Sectional Studies ; HIV ; Hepacivirus ; CD4 Lymphocyte Count

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.
Autorzy:: Hashempour A; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Khodadad N; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaei R; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezaei B; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghasabi F; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Falahi S; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Kenarkouhi A; Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Davarpanah MA; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 28; Vol. 24 (1), pp. 358. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Anti-HIV Agents*
Adult ; Humans ; Iran ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Treatment Failure ; Viral Load ; CD4 Lymphocyte Count ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Diabetes mellitus and associated risk factors among HIV infected patients on HAART.
Autorzy:: Kanyara L; Kenya Medical Research Institute, Nairobi, Kenya. .
Lel R; Kenya Medical Research Institute, Nairobi, Kenya.
Kageha S; Kenya Medical Research Institute, Nairobi, Kenya.
Kinyua J; Kenya Medical Research Institute, Nairobi, Kenya.
Matu S; Kenya Medical Research Institute, Nairobi, Kenya.
Ongaya A; Kenya Medical Research Institute, Nairobi, Kenya.
Matilu M; Kenya Medical Research Institute, Nairobi, Kenya.
Mwangi P; Kenya Medical Research Institute, Nairobi, Kenya.
Okoth V; Kenya Medical Research Institute, Nairobi, Kenya.
Mwangi J; Kenya Medical Research Institute, Nairobi, Kenya.
Olungae D; Kenya Medical Research Institute, Nairobi, Kenya.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Mar 19; Vol. 24 (1), pp. 846. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/complications
Diabetes Mellitus*/epidemiology
Humans ; Antiretroviral Therapy, Highly Active ; Cross-Sectional Studies ; Kenya/epidemiology ; Risk Factors ; Glucose/therapeutic use ; Prevalence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Survival trends among people living with human immunodeficiency virus on antiretroviral treatment in two rural districts in Ghana.
Autorzy:: Sackeya E; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Tatale District Hospital, Tatale, Northern Region, Ghana.
Beru MM; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Tamale Teaching Hospital, Tamale Metropolitan, Tamale, Ghana.
Angmortey RN; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Tamale Teaching Hospital, Tamale Metropolitan, Tamale, Ghana.
Opoku DA; Allen Clinic, Family Health Services, Kumasi, Ghana.; Department of Global Health and Internal Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Boakye K; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Baatira M; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; St. Joseph's Midwifery Training College, Jirapa, Ghana.
Yakubu MS; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Nursing and Midwifery Training College, Nalerigu-Ghana.
Mohammed A; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Ayisi-Boateng NK; Department of Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Boateng D; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Julius Global Health, Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utrecht, The Netherlands.
Nakua EK; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Edusei AK; Department of Health Promotion, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 06; Vol. 19 (3), pp. e0290810. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Retroviral Agents*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Middle Aged ; Ghana/epidemiology ; Retrospective Studies ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.
Autorzy:: Castillo-Rozas G; Laboratory of Molecular and Cellular Virology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.
Tu S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Luz PM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Mejia F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Sierra-Madero J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Rouzier V; Groupe Haitien d'Etudes du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti.
Shepherd BE; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Cortes CP; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Internal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.; Hospital Clínico San Borja Arriarán & Fundación Arriarán, Santiago, Chile.; Millenium Institute on Immunology and Immunotherapy, Santiago, Chile.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26214.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Retrospective Studies ; Risk Factors ; Drug Therapy, Combination ; CD4 Lymphocyte Count ; Viral Load ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Predictors for viral load suppression among HIV positive adults under ART treatment in University of Gondar Comprehensive Specialized Hospital: retrospective cohort study.
Autorzy:: Muhie NS; Department of Statistics, College of Natural and Computational Science, Mekdela Amba University, Tulu Awuliya, Ethiopia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3258. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Adult ; Humans ; Retrospective Studies ; Viral Load ; Antiretroviral Therapy, Highly Active ; Hospitals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Dolutegravir based therapy showed CD4 T cell count recovery and viral load suppression among ART naïve people living with HIV AIDS: a pilot evaluation.
Autorzy:: Gebremedhin T; University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia.
Aynalem M; Department of Hematology and Immunohematology, University of Gondar, Gondar, Ethiopia.
Adem M; Department of Immunology and Molecular Biology, University of Gondar, Gondar, Ethiopia.
Geremew D; Department of Medical Laboratory Sciences, Immunology and Molecular Biology Unit, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Aleka Y; Department of Immunology and Molecular Biology, University of Gondar, Gondar, Ethiopia. .
Kiflie A; Department of Immunology and Molecular Biology, University of Gondar, Gondar, Ethiopia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3297. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Acquired Immunodeficiency Syndrome*/drug therapy
HIV Infections*
Anti-HIV Agents*/pharmacology
HIV-1*/genetics
Heterocyclic Compounds, 3-Ring*
Oxazines*
Piperazines*
Pyridones*
Humans ; Antiretroviral Therapy, Highly Active ; Prospective Studies ; Viral Load ; Pilot Projects ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes ; RNA/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006-2020.
Autorzy:: Niu D; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiao T; Luzhou Prefectural Center for Disease Control and Prevention, Sichuan, China.
Chen Y; School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China.
Tang H; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chen F; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Cai C; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Qin Q; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao D; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jin Y; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang S; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Hou Y; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Lu Z; School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China.
Yang L; School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China.
Liu H; Luzhou Prefectural Center for Disease Control and Prevention, Sichuan, China.
Xie D; Luzhou Prefectural Center for Disease Control and Prevention, Sichuan, China.
Zou H; School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China. .
Lyu F; Division of Epidemiology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Mar 29; Vol. 23 (1), pp. 186. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Infections*/drug therapy
Female ; Humans ; Male ; Adult ; Middle Aged ; Aged ; Retrospective Studies ; CD4 Lymphocyte Count ; China/epidemiology ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Undernutrition increased the risk of loss to follow-up among adults living with HIV on ART in Northwest Ethiopia: a retrospective cohort study.
Autorzy:: Alebel A; College of Health Science, Debre Markos University, Debre Markos, Ethiopia. .; School of Public Health, Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia. .
Sibbritt D; School of Public Health, Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.
Petrucka P; College of Nursing, University of Saskatchewan, Saskatoon, Canada.; School of Life Sciences and Bioengineering, Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania.
Demant D; School of Public Health, Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.; School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD, Australia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Dec 29; Vol. 12 (1), pp. 22556. Date of Electronic Publication: 2022 Dec 29.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Malnutrition*/complications
Malnutrition*/epidemiology
Antiretroviral Therapy, Highly Active*
Adult ; Humans ; Ethiopia/epidemiology ; Follow-Up Studies ; HIV ; Proportional Hazards Models ; Retrospective Studies ; Lost to Follow-Up

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Survival and Predictors of Mortality among Adults Initiating Highly Active Antiretroviral Therapy in Ethiopia: A Retrospective Cohort Study (2007-2019).
Autorzy:: Getaneh Y; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Ning F; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
He Q; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Rashid A; School of Medicine, Nankai University, Tianjin, China.
Kassa D; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Assefa Y; University of Queensland, School of Public Health, Queensland, Australia.
Yi F; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Liao L; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Shao Y; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.; Changping Laboratory, Beijing, China.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2022 Nov 23; Vol. 2022, pp. 5884845. Date of Electronic Publication: 2022 Nov 23 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Adult ; Humans ; Ethiopia/epidemiology ; Retrospective Studies ; CD4 Lymphocyte Count ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Four-dimensional magnetic resonance after ascending aorta replacement and aortic valve repair with HAART 300 internal annuloplasty ring.
Autorzy:: Engel JS; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Ilinois, USA.
Bharadwaj S; Department of Surgery, Division of Cardiac Surgery, Northwestern University, Chicago, Ilinois, USA.
Elbaz M; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Ilinois, USA.; Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, USA.
Markl M; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Ilinois, USA.; Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, USA.
Allen BD; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Ilinois, USA.
Malaisrie SC; Department of Surgery, Division of Cardiac Surgery, Northwestern University, Chicago, Ilinois, USA.; Pokaż więcej
Źródło:: Journal of cardiac surgery [J Card Surg] 2022 Nov; Vol. 37 (11), pp. 3899-3903. Date of Electronic Publication: 2022 Sep 18.
Typ publikacji:: Case Reports
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Aortic Valve*/surgery
Aorta/surgery ; Blood Flow Velocity ; Hemodynamics ; Humans ; Magnetic Resonance Spectroscopy ; Technology

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.
Autorzy:: Stam AJ; Translational Virology Research Group, Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Department of Infectious Diseases, Public Health Service Amsterdam, 1018 WT Amsterdam, The Netherlands.
Buchholtz NVEJ; Translational Virology Research Group, Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Bierman WFW; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
van Crevel R; Department of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Hoepelman AIM; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Claassen MAA; Department of Internal Medicine, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands.
Ammerlaan HSM; Department of Internal Medicine, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
van Welzen BJ; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
van Kasteren MEE; Department of Internal Medicine, ETZ Hospital, 5022 GC Tilburg, The Netherlands.
van Lelyveld SFL; Department of Internal Medicine, Spaarne Gasthuis, 2000 TM Hoofddorp, The Netherlands.
de Jong D; Translational Virology Research Group, Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Tesselaar K; Department of Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
van Luin M; Department of Clinical Pharmacy, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Nijhuis M; Translational Virology Research Group, Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Wensing AMJ; Translational Virology Research Group, Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Lowerit Study Team; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Jan 25; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Anti-HIV Agents*/pharmacology
Humans ; Darunavir/therapeutic use ; Darunavir/pharmacology ; Viremia ; Antiretroviral Therapy, Highly Active ; Sequence Analysis ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Weight loss and mortality in people living with HIV: a systematic review and meta-analysis.
Autorzy:: Cordeiro SA; Program in Health Sciences (PPGCIS), Faculty of Medicine, Federal University of Amazonas - UFAM, Afonso Pena Street, 1053, Centro, Manaus, Amazonas, Brazil. .
Lopes TCP; Program in Health Sciences (PPGCIS), Faculty of Medicine, Federal University of Amazonas - UFAM, Afonso Pena Street, 1053, Centro, Manaus, Amazonas, Brazil.
Boechat AL; Program in Health Sciences (PPGCIS), Faculty of Medicine, Federal University of Amazonas - UFAM, Afonso Pena Street, 1053, Centro, Manaus, Amazonas, Brazil.
Gonçalves RL; Program in Health Sciences (PPGCIS), Faculty of Medicine, Federal University of Amazonas - UFAM, Afonso Pena Street, 1053, Centro, Manaus, Amazonas, Brazil.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 34. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Adult ; Humans ; Male ; Antiretroviral Therapy, Highly Active ; Ethiopia ; Prospective Studies ; Weight Loss ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: EcoHIV-Infected Mice Show No Signs of Platelet Activation.
Autorzy:: Alfar HR; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.
Nthenge-Ngumbau DN; Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.
Saatman KE; Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.
Whiteheart SW; Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Dec 29; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Seropositivity*
HIV-1*
Animals ; Mice ; Platelet Activation ; Blood Platelets ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Advancements in Cell-Based Therapies for HIV Cure.
Autorzy:: Matsui Y; Gladstone Institute of Virology, Gladstone Institutes, 1650 Owens St., San Francisco, CA 941578, USA.
Miura Y; Department of Transfusion Medicine and Cell Therapy, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake, Toyoake 470-1192, Aichi, Japan.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Dec 28; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:: Journal Article; Review
MeSH Terms:: HIV Infections*/therapy
Acquired Immunodeficiency Syndrome*/therapy
Humans ; HIV ; Antiretroviral Therapy, Highly Active ; Cell- and Tissue-Based Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Impact of Protease Inhibitor-Based Highly Active Antiretroviral Therapy on Fetal Subcutaneous Fat Tissue in HIV-Pregnant Women in a Middle-Income Country.
Autorzy:: Borboa-Olivares H; Community Interventions Research Branch, Instituto Nacional de Perinatología, Mexico City 11000, Mexico.
Estrada-Gutierrez G; Research Direction, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.
Martinez-Portilla RJ; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, Mexico.
Espino-Y-Sosa S; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, Mexico.
Flores-Pliego A; Department of Immunobiochemistry, Instituto Nacional de Perinatología, Mexico City 11000, Mexico.
Espejel-Nuñez A; Department of Immunobiochemistry, Instituto Nacional de Perinatología, Mexico City 11000, Mexico.
Camacho-Arroyo I; Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 11000, Mexico.
Solis-Paredes JM; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, Mexico.
Villafan-Bernal JR; Laboratory of Immunogenomics and Metabolic Diseases, Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
Torres-Torres J; Clinical Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, Mexico.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Dec 20; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Adult ; Child ; Humans ; Female ; Infant, Newborn ; Pregnancy ; Adolescent ; Antiretroviral Therapy, Highly Active/adverse effects ; Protease Inhibitors/therapeutic use ; Pregnant Women ; Infectious Disease Transmission, Vertical/prevention & control ; Antiviral Agents/therapeutic use ; Reverse Transcriptase Inhibitors/therapeutic use ; Fetus ; Subcutaneous Fat

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at University of Gondar Comprehensive and Specialized Hospital, Ethiopia.
Autorzy:: Muhie NS; Mekdela Amba University, Tulu Awuliya, Ethiopia. .
Tegegne AS; Bahir Dar University, Bahir Dar, Ethiopia.; Pokaż więcej
Źródło:: BMC research notes [BMC Res Notes] 2023 Dec 02; Vol. 16 (1), pp. 357. Date of Electronic Publication: 2023 Dec 02.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/complications
Acquired Immunodeficiency Syndrome*/drug therapy
Humans ; Adult ; Female ; Antiretroviral Therapy, Highly Active ; Retrospective Studies ; Follow-Up Studies ; Ethiopia/epidemiology ; Bayes Theorem ; CD4 Lymphocyte Count ; Hospitals, Special ; Hemoglobins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 21.

Tytuł:: Zinc improves sexual and erectile function in HAART-treated rats via the upregulation of erectogenic enzymes and maintenance of redox balance.
Autorzy:: Akhigbe RE; Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.; Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria.
Hamed MA; Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria.; Department of Medical Laboratory Science, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.; The Brainwill Laboratories and Biomedical Services, Osogbo, Osun State, Nigeria.
Odetayo AF; Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria.; Department of Physiology, University of Ilorin, Ilorin, Kwara State, Nigeria.
Akhigbe TM; Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria.; Department of Agronomy, Osun State University (Ejigbo Campus), Osogbo, Nigeria.
Oyedokun PA; Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.; Pokaż więcej
Źródło:: The aging male : the official journal of the International Society for the Study of the Aging Male [Aging Male] 2023 Dec; Vol. 26 (1), pp. 2205517.
Typ publikacji:: Journal Article
MeSH Terms:: Penile Erection*/physiology
Erectile Dysfunction*/chemically induced
Erectile Dysfunction*/drug therapy
Humans ; Male ; Rats ; Animals ; Acetylcholinesterase/therapeutic use ; Up-Regulation ; Antiretroviral Therapy, Highly Active/adverse effects ; Zinc/therapeutic use ; Rats, Wistar ; Oxidation-Reduction

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 22.

Tytuł:: Investigating the Role of Anti-TPO Antibodies in HIV-Associated Thrombocytopenia before and after Initiation of HAART: A Case-Control Longitudinal Study.
Autorzy:: Tsiakalos A; Leto General, Maternity & Gynecology Clinic, 11524 Athens, Greece.
Routsias JG; Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Schinas G; School of Medicine, University of Patras, 26504 Rio, Greece.
Georgiadou S; Department of Medicine and Research Laboratory of Internal Medicine, General University Hospital of Larissa, 41110 Larissa, Greece.
Sipsas NV; Laiko General Hospital of Athens and Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Akinosoglou K; School of Medicine, University of Patras, 26504 Rio, Greece.; Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Rio, Greece.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Nov 08; Vol. 15 (11). Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/complications
HIV Infections*/drug therapy
Thrombocytopenia*/etiology
Humans ; Antiretroviral Therapy, Highly Active ; Case-Control Studies ; Longitudinal Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 23.

Tytuł:: "I am alive because of her": factors affecting adherence to combination antiretroviral therapy among people living with HIV in KwaZulu-Natal, South Africa.
Autorzy:: Loveday M; HIV Prevention Research Unit, South African Medical Research Council, Durban, KwaZulu-Natal, South Africa.; CAPRISA-MRC HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Furin J; Department of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Ave., Boston, MA, 02115, USA. .
Hlangu S; HIV Prevention Research Unit, South African Medical Research Council, Durban, KwaZulu-Natal, South Africa.
Naidoo T; R. K. Khan Hospital HAST Unit, Department of Health, Durban, KwaZulu-Natal, South Africa.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2022 Aug 08; Vol. 22 (1), pp. 680. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:: Journal Article
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Infections*/drug therapy
HIV Infections*/psychology
Female ; Humans ; Male ; Medication Adherence ; Qualitative Research ; South Africa

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 24.

Tytuł:: Real-World Effectiveness of COVID-19 Vaccine and Identification of SARS-CoV-2 Variants among People Living with HIV on Highly Active Antiretroviral Therapy in Central Kerala of India-An Ambi-Directional Cohort Study.
Autorzy:: Thomas J; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Rajmohan P; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Jose P; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Kannan R; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Jose R; Department of Microbiology, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Uttumadathil Gopinathan U; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Raphael L; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Baiju NM; Department of Transfusion Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Krishna S; KEM Hospital Research Centre, Pune 412216, Maharashtra, India.
Attokaran T; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Bency A T J; Department of Community Medicine, PK DAS Medical College, Vaniyamkulam 679522, Kerala, India.
Venugopal A; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Sheela S; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Kallempadam A; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Jose L; Department of Community Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Innah SJ; Department of Transfusion Medicine, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
Varghese PR; Jubilee Centre for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
George A; Jubilee Centre for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Oct 30; Vol. 15 (11). Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/prevention & control
Lepidoptera*
HIV Infections*/complications
HIV Infections*/drug therapy
Humans ; Animals ; Adult ; Middle Aged ; SARS-CoV-2/genetics ; COVID-19 Vaccines ; ChAdOx1 nCoV-19 ; Antiretroviral Therapy, Highly Active ; Cohort Studies ; Vaccination ; India/epidemiology
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 25.

Tytuł:: Metabolic and mitochondrial dysregulation in CD4+ T cells from HIV-positive women on combination anti-retroviral therapy.
Autorzy:: Akiso M; Department of Medical Microbiology & Immunology, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.; KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, Nairobi, Kenya.
Ameka M; KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, Nairobi, Kenya.
Naidoo K; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Langat R; KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, Nairobi, Kenya.; Division of Surgical Outcomes and Precision Medicine Research, Department of Surgery, University of Minnesota Twin Cities, United States of America.
Kombo J; Department of Medical Microbiology & Immunology, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.; KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, Nairobi, Kenya.
Sikuku D; Department of Medical Microbiology & Immunology, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.
Ndung'u T; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Altfeld M; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Virus Immunology Department, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Anzala O; Department of Medical Microbiology & Immunology, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.; KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, Nairobi, Kenya.
Mureithi M; Department of Medical Microbiology & Immunology, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.; KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, Nairobi, Kenya.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Oct 10; Vol. 18 (10), pp. e0286436. Date of Electronic Publication: 2023 Oct 10 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: CD4-Positive T-Lymphocytes*
HIV Infections*
Humans ; Female ; Leukocytes, Mononuclear/metabolism ; Fluorescein-5-isothiocyanate/metabolism ; CD8-Positive T-Lymphocytes ; Glucose/metabolism ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 26.

Tytuł:: Norovirus infection among HIV-infected patients in Abuja, Nigeria: impact of combination antiretroviral therapy status.
Autorzy:: Osazuwa F; Department of Medical Laboratory Sciences, University of Benin, Benin City, Nigeria. .; MDS Molecular Services, Sub-Saharan African Office, Abuja, Nigeria. .; Laboratory of Molecular Virology, Biotech Africa Genomics, West African Region Office, Abuja, Nigeria. .
Johnson WO; MDS Molecular Services, Sub-Saharan African Office, Abuja, Nigeria.
Grobler HS; MDS Molecular Services, Sub-Saharan African Office, Abuja, Nigeria.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Sep 21; Vol. 23 (1), pp. 623. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Caliciviridae Infections*/epidemiology
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Norovirus*
Adolescent ; Adult ; Humans ; Middle Aged ; Young Adult ; Antiretroviral Therapy, Highly Active ; Bone Screws ; Nigeria/epidemiology ; Male ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 27.

Tytuł:: Impact factors of Blastocystis hominis infection in persons living with human immunodeficiency virus: a large-scale, multi-center observational study from China.
Autorzy:: Zhang SX; Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Wang JC; Department of Science and Technology, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Li ZW; Gansu Province People's Hospital, Gansu Provincial Hospital, Lanzhou, 730000, China.
Zheng JX; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhou WT; National Health Commission (NHC) Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Yang GB; Gansu Provincial Center for Disease Control and Prevention, Lanzhou, 730000, China.
Yu YF; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Wu XP; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lv S; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Liu Q; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Chen MX; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lu Y; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China.; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Dou ZH; National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention, Beijing, 102206, China.
Zhang DW; The People's Liberation Army 302 Hospital, Beijing, 100039, China.
Lv WW; Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Wang L; Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Lu ZH; Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Yang M; Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Zheng PY; Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Chen YL; Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Tian LG; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China. .; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Zhou XN; Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai, 200025, China. .; School of Global Health, Chinese Center for Tropical Diseases Research-Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .; Pokaż więcej
Źródło:: Infectious diseases of poverty [Infect Dis Poverty] 2023 Sep 11; Vol. 12 (1), pp. 82. Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: HIV*
Blastocystis Infections*/complications
Blastocystis Infections*/epidemiology
Humans ; Female ; Adult ; Male ; Cross-Sectional Studies ; China/epidemiology ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 28.

Tytuł:: Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy.
Autorzy:: Kim J; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
Kim C; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Lee JA; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Lee SJ; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Lee KH; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Kim JH; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea. .; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea. .
Ahn JY; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Jeong SJ; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Ku NS; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Yeom JS; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Song YG; Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Aug 31; Vol. 13 (1), pp. 14291. Date of Electronic Publication: 2023 Aug 31.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/complications
Leukoencephalopathy, Progressive Multifocal*/diagnosis
Humans ; Retrospective Studies ; Prognosis ; Antiretroviral Therapy, Highly Active ; Immunosuppressive Agents

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 29.

Tytuł:: High risk of virologic failure among HIV-infected children and adolescents routinely followed-up in Littoral region of Cameroon.
Autorzy:: Mbébi Enoné PJ; Faculty of Sciences, Department of Animal Biology and Physiology, University of Douala, Douala, Cameroon.
Penda CI; Faculty of Medicine and Pharmaceutical Sciences, Clinical Sciences Department, University of Douala, Douala, Cameroon.; Accredited HIV Care Center, Laquintinie Hospital of Douala, Douala, Cameroon.
Ngondi G; Faculty of Medicine and Pharmaceutical Sciences, Biological Sciences Department, University of Douala, Douala, Cameroon.; Biological Laboratory, Laquintinie Hospital of Douala, Douala, Cameroon.
Fokam J; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.; Faculty of Health Sciences, Department of Medical Laboratory Science, University of Buea, Buea, Cameroon.
Ebong SB; Faculty of Sciences, Department of Animal Biology and Physiology, University of Douala, Douala, Cameroon.
Mekoulou Ndongo J; Faculty of Sciences, Department of Animal Biology and Physiology, University of Douala, Douala, Cameroon.
Essangui Same EG; Faculty of Medicine and Pharmaceutical Sciences, Biological Sciences Department, University of Douala, Douala, Cameroon.
Ndjengue Nson LS; Accredited HIV Care Center, Laquintinie Hospital of Douala, Douala, Cameroon.
Mandengue SH; Faculty of Sciences, Department of Animal Biology and Physiology, University of Douala, Douala, Cameroon.
Eboumbou Moukoko CE; Faculty of Medicine and Pharmaceutical Sciences, Biological Sciences Department, University of Douala, Douala, Cameroon.; Laboratory of Parasitology, Mycology and Virology, Postgraduate Training Unit for Health Sciences, Postgraduate School for Pure and Applied Sciences, University of Douala, Douala, Cameroon.; Centre Pasteur of Cameroon, Yaounde, Cameroon.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Aug 10; Vol. 18 (8), pp. e0289426. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Child ; Adolescent ; Cohort Studies ; Cameroon/epidemiology ; Prospective Studies ; Antiretroviral Therapy, Highly Active ; Viral Load ; Treatment Failure

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 30.

Tytuł:: Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques.
Autorzy:: Podgorski RM; Center for NeuroVirology and Gene Editing, Department of Microbiology, Immunology, and Inflammation, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Robinson JA; Center for NeuroVirology and Gene Editing, Department of Microbiology, Immunology, and Inflammation, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Smith MD; Center for NeuroVirology and Gene Editing, Department of Microbiology, Immunology, and Inflammation, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Mallick S; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Zhao H; Center for Biostatistics and Epidemiology, Department of Biomedical Education and Data Science, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Veazey RS; Tulane National Primate Research Center, Tulane School of Medicine, Covington, LA, USA.
Kolson DL; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Bar KJ; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .
Burdo TH; Center for NeuroVirology and Gene Editing, Department of Microbiology, Immunology, and Inflammation, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. .; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2023 Aug 10; Vol. 20 (1), pp. 13. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Simian Acquired Immunodeficiency Syndrome*/drug therapy
HIV Infections*/drug therapy
Simian Immunodeficiency Virus*/genetics
HIV-1*/genetics
Animals ; Humans ; Macaca mulatta ; Antiretroviral Therapy, Highly Active ; Brain ; Virus Replication/physiology ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 31.

Tytuł:: Determinants of CD4 count and risk for death of HIV infected children under ART.
Autorzy:: Gwadu AA; Department of Statistics, Dire Dawa University, Dire Dawa, Ethiopia.
Tegegne AS; Department of Statistics, Bahir Dar University, Bahir Dar, Ethiopia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Apr 27; Vol. 12 (1), pp. 6867. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:: Journal Article
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Infections*/diagnosis
HIV Infections*/drug therapy
CD4 Lymphocyte Count ; Child ; Humans ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 32.

Tytuł:: Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort study.
Autorzy:: McClean AR; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont. .
Trigg J; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Ye M; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
McLinden T; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Kooij KW; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Bacani N; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Hui C; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Sereda P; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Burchell AN; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Walmsley SL; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Kelly D; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Machouf N; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Montaner JSG; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Loutfy M; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.
Hogg RS; British Columbia Centre for Excellence in HIV/AIDS (McClean, Trigg, Ye, McLinden, Kooij, Bacani, Sereda, Montaner, Hogg); Faculty of Medicine (McClean, Montaner), University of British Columbia, Vancouver, BC; Faculty of Health Sciences (Kooij, Hogg), Simon Fraser University, Burnaby, BC; Faculty of Arts (Hui), Ryerson University, Toronto Ont.; Canadian Institutes of Health Research Canadian HIV Trials Network (Hui, Walmsley), Vancouver, BC; Department of Family and Community Medicine (Burchell), St. Michael's Hospital, Unity Health Toronto; Department of Family and Community Medicine (Burchell), Faculty of Health Sciences, University of Toronto; University Health Network (Walmsley), Toronto, Ont.; Faculty of Medicine and School of Pharmacy (Kelly), Memorial University of Newfoundland, St. John's, NL; Clinique de Médecine Urbaine du Quartier Latin (Machouf), Montréal, Que.; Division of Infectious Disease (Loutfy), Department of Medicine, University of Toronto; Women's College Hospital (Loutfy), Toronto, Ont.; Pokaż więcej
Corporate Authors:: CANOC Collaboration
Źródło:: CMAJ open [CMAJ Open] 2022 Mar 15; Vol. 10 (1), pp. E183-E189. Date of Electronic Publication: 2022 Mar 15 (Print Publication: 2022).
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Canada/epidemiology ; Cohort Studies ; Humans ; Longitudinal Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 33.

Tytuł:: Joint calibrated estimation of inverse probability of treatment and censoring weights for marginal structural models.
Autorzy:: Yiu S; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0SR, UK.
Su L; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0SR, UK.; Pokaż więcej
Źródło:: Biometrics [Biometrics] 2022 Mar; Vol. 78 (1), pp. 115-127. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji:: Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Models, Statistical*
CD4 Lymphocyte Count ; Causality ; Models, Structural ; Probability ; Propensity Score

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 34.

Tytuł:: Effects of a four-week aerobic exercise programme on depression, anxiety and general self-efficacy in people living with HIV on highly active anti-retroviral therapy.
Autorzy:: Odunaiya NA; Department of Physiotherapy, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Agbaje SA; Department of Physiotherapy, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adegoke OM; Department of Physiotherapy, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Oguntibeju OO; Department of Biomedical Sciences, Faculty of Health & Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa.; Pokaż więcej
Źródło:: AIDS care [AIDS Care] 2022 Feb; Vol. 34 (2), pp. 173-181. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji:: Journal Article
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Infections*/psychology
Anxiety/therapy ; Depression/therapy ; Exercise ; Exercise Therapy ; Humans ; Nigeria ; Self Efficacy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 35.

Tytuł:: Identifying barriers to ART initiation and adherence: An exploratory qualitative study on PMTCT in Zambia.
Autorzy:: Kanguya T; Centre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Koyuncu A; Centre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Sharma A; Centre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Kusanathan T; Department of Gender Studies, University of Zambia, Lusaka, Zambia.
Mubanga M; Centre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Chi BH; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Vinikoor MJ; University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Mubiana-Mbewe M; Centre for Infectious Diseases Research in Zambia, Lusaka, Zambia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Jan 13; Vol. 17 (1), pp. e0262392. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Antiretroviral Therapy, Highly Active/*psychology
Medication Adherence/*psychology
Patient Compliance/*psychology
Adult ; Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/methods ; Antiretroviral Therapy, Highly Active/trends ; Female ; Focus Groups ; HIV Infections/drug therapy ; Humans ; Infectious Disease Transmission, Vertical ; Male ; Medication Adherence/statistics & numerical data ; Patient Compliance/statistics & numerical data ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; Pregnant Women ; Qualitative Research ; Sexual Partners ; Zambia/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 36.

Tytuł:: Neuroinflammatory Profiling in SIV-Infected Chinese-Origin Rhesus Macaques on Antiretroviral Therapy.
Autorzy:: Solis-Leal A; Host-Pathogen Interaction Program, Texas Biomedical Research Institute, 8715 W Military Dr., San Antonio, TX 78227, USA.
Siddiqui S; Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA.
Wu F; Host-Pathogen Interaction Program, Texas Biomedical Research Institute, 8715 W Military Dr., San Antonio, TX 78227, USA.; Tulane Center for Aging, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Mohan M; Host-Pathogen Interaction Program, Texas Biomedical Research Institute, 8715 W Military Dr., San Antonio, TX 78227, USA.
Hu W; Center for Metabolic Disease Research, Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19122, USA.
Doyle-Meyers LA; Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA.
Dufour JP; Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA.
Ling B; Host-Pathogen Interaction Program, Texas Biomedical Research Institute, 8715 W Military Dr., San Antonio, TX 78227, USA.; Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA.; Tulane Center for Aging, School of Medicine, Tulane University, New Orleans, LA 70112, USA.; Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA 70112, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2022 Jan 13; Vol. 14 (1). Date of Electronic Publication: 2022 Jan 13.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Simian Immunodeficiency Virus*
Transcriptome*
Macaca mulatta/*virology
Neuroinflammatory Diseases/*genetics
Neuroinflammatory Diseases/*metabolism
Simian Acquired Immunodeficiency Syndrome/*genetics
Simian Acquired Immunodeficiency Syndrome/*metabolism
Animals ; Brain ; Central Nervous System ; Chemokines/metabolism ; China ; Cytokines/metabolism ; Disease Models, Animal ; Gene Expression ; Gene Expression Profiling ; HIV ; HIV Infections/blood ; HIV Infections/genetics ; HIV Infections/metabolism ; Influenza A virus ; Simian Acquired Immunodeficiency Syndrome/blood ; Simian Acquired Immunodeficiency Syndrome/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 37.

Tytuł:: Impact of Combined Antiretroviral Therapy on Metabolic Syndrome Components in Adult People Living with HIV: A Literature Review.
Autorzy:: Sapuła M; Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland.
Suchacz M; Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland.
Załęski A; Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland.
Wiercińska-Drapało A; Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, 01-201 Warsaw, Poland.; Pokaż więcej
Źródło:: Viruses [Viruses] 2022 Jan 11; Vol. 14 (1). Date of Electronic Publication: 2022 Jan 11.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Metabolic Syndrome*
Anti-Retroviral Agents/*therapeutic use
Antiretroviral Therapy, Highly Active/*adverse effects
HIV Infections/*drug therapy
Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/methods ; Diabetes Mellitus ; Humans ; Hypertension ; Obesity ; Weight Gain/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 38.

Tytuł:: Addressing an HIV cure in LMIC.
Autorzy:: Ismail SD; Division of Medical Virology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa.
Pankrac J; Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A5C1, Canada.
Ndashimye E; Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A5C1, Canada.; Center for AIDS Research Uganda Laboratories, Joint Clinical Research Centre, Kampala, Uganda.
Prodger JL; Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A5C1, Canada.; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A 5C1, Canada.; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abrahams MR; Division of Medical Virology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa.
Mann JFS; Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A5C1, Canada.; Bristol Veterinary School, University of Bristol, Langford House, Langford, Bristol, BS40 5DU, UK.
Redd AD; Division of Medical Virology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa.; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.
Arts EJ; Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A5C1, Canada. .; Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA. .; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2021 Aug 03; Vol. 18 (1), pp. 21. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji:: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Antiretroviral Therapy, Highly Active/*standards
Developing Countries/*statistics & numerical data
Disease Reservoirs/*virology
HIV Infections/*drug therapy
Virus Latency/*drug effects
Africa South of the Sahara/epidemiology ; Antiretroviral Therapy, Highly Active/methods ; Antiretroviral Therapy, Highly Active/statistics & numerical data ; Cost of Illness ; HIV Infections/epidemiology ; HIV Infections/prevention & control ; HIV-1/genetics ; HIV-1/pathogenicity ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 39.

Tytuł:: Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial.
Autorzy:: Amstutz A; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Lejone TI; SolidarMed, Maseru, Lesotho.
Khesa L; SolidarMed, Maseru, Lesotho.
Kopo M; SolidarMed, Maseru, Lesotho.
Kao M; SolidarMed, Maseru, Lesotho.
Muhairwe J; SolidarMed, Maseru, Lesotho.
Bresser M; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Räber F; University of Basel, Basel, Switzerland.
Klimkait T; University of Basel, Basel, Switzerland.; Molecular Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Battegay M; University of Basel, Basel, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Glass TR; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Labhardt ND; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2021 Oct 21; Vol. 18 (10), pp. e1003839. Date of Electronic Publication: 2021 Oct 21 (Print Publication: 2021).
Typ publikacji:: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Community Health Workers*
Adult ; Cluster Analysis ; Endpoint Determination ; Female ; Follow-Up Studies ; Humans ; Lesotho ; Male ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 40.

Tytuł:: Alterations in children's sub-dominant gut microbiota by HIV infection and anti-retroviral therapy.
Autorzy:: Nguyen QT; Department of Viral infection and International Health, Graduate school of Medical Science, Kanazawa University, Kanazawa, Japan.
Ishizaki A; Department of Viral infection and International Health, Graduate school of Medical Science, Kanazawa University, Kanazawa, Japan.
Bi X; Department of Viral infection and International Health, Graduate school of Medical Science, Kanazawa University, Kanazawa, Japan.
Matsuda K; Yakult Central Institute, Tokyo, Japan.
Nguyen LV; Vietnam National Children's Hospital, Hanoi, Viet Nam.
Pham HV; Vietnam National Children's Hospital, Hanoi, Viet Nam.
Phan CTT; Vietnam National Children's Hospital, Hanoi, Viet Nam.
Phung TTB; Vietnam National Children's Hospital, Hanoi, Viet Nam.
Ngo TTT; Vietnam National Children's Hospital, Hanoi, Viet Nam.
Nguyen AV; Vietnam National Children's Hospital, Hanoi, Viet Nam.
Khu DTK; Vietnam National Children's Hospital, Hanoi, Viet Nam.
Ichimura H; Department of Viral infection and International Health, Graduate school of Medical Science, Kanazawa University, Kanazawa, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Oct 11; Vol. 16 (10), pp. e0258226. Date of Electronic Publication: 2021 Oct 11 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Gastrointestinal Microbiome*
HIV Infections/*drug therapy
HIV Infections/*microbiology
Age Factors ; Bacteria/genetics ; Child ; Child, Preschool ; Female ; HIV Infections/immunology ; Humans ; Linear Models ; Male ; Principal Component Analysis ; Staphylococcus/drug effects ; Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 41.

Tytuł:: Guillain-Barré syndrome as the first presentation of human immunodeficiency virus infection.
Autorzy:: Lopes M; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. .
Marques P; Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Silva B; Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Cruz G; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Serra JE; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Ferreira E; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Alves H; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
da Cunha JS; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Pokaż więcej
Źródło:: BMC neurology [BMC Neurol] 2021 Aug 18; Vol. 21 (1), pp. 321. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Primary Dysautonomias*
Adrenal Cortex Hormones/*therapeutic use
Guillain-Barre Syndrome/*complications
HIV Infections/*drug therapy
Immunoglobulins, Intravenous/*therapeutic use
Muscle Weakness/*etiology
Adrenal Cortex Hormones/administration & dosage ; Guillain-Barre Syndrome/diagnosis ; Guillain-Barre Syndrome/drug therapy ; HIV Infections/complications ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Male ; Middle Aged ; Muscle Weakness/drug therapy ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 42.

Tytuł:: To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
Autorzy:: Lebelonyane R; Ministry of Health and Wellness, Gaborone, Botswana.
Bachanas P; U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Block L; Northrop Grumman, Atlanta, GA, United States of America.
Ussery F; U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Alwano MG; U.S. Centers for Disease Control and Prevention, Gaborone, Botswana.
Marukutira T; U.S. Centers for Disease Control and Prevention, Gaborone, Botswana.
El Halabi S; Ministry of Health and Wellness, Gaborone, Botswana.
Roland M; U.S. Centers for Disease Control and Prevention, Gaborone, Botswana.
Abrams W; U.S. Centers for Disease Control and Prevention, Gaborone, Botswana.
Ussery G; Northrop Grumman, Atlanta, GA, United States of America.
Miller JA; Northrop Grumman, Atlanta, GA, United States of America.
Lockman S; Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Gaolathe T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Holme MP; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Hader S; UNAIDS, Geneva, Switzerland.
Mills LA; U.S. Centers for Disease Control and Prevention, Gaborone, Botswana.
Wirth K; Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
Bock N; U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Moore J; U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Aug 10; Vol. 16 (8), pp. e0255227. Date of Electronic Publication: 2021 Aug 10 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Testing*
Health Knowledge, Attitudes, Practice*
HIV Infections/*drug therapy
HIV Infections/*virology
Adolescent ; Adult ; Botswana/epidemiology ; Family Characteristics ; Female ; HIV Infections/epidemiology ; Humans ; Male ; Middle Aged ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 43.

Tytuł:: Antiretroviral Treatment-Induced Galectin-9 Might Impact HIV Viremia in Addition to Contributing to Inflammaging.
Autorzy:: Shete A; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Wagh V; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Sawant J; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Shidhaye P; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Sane S; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Rao A; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Kulkarni S; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Ghate M; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 31; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Antiretroviral Therapy, Highly Active ; Viremia/drug therapy ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 44.

Tytuł:: Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.
Autorzy:: Volkow P; Infectious Disease Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Chavez Galan L; Integrative Inmunology Laboratory, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Ramon-Luing L; Integrative Inmunology Laboratory, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Cruz-Velazquez J; Cytogenetic Laboratory, Instituto Nacional de Cancerología, Mexico City, Mexico.
Cornejo-Juarez P; Infectious Disease Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Sada-Ovalle I; Integrative Inmunology Laboratory, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Perez-Padilla R; Department of Research on Tobacco and COPD, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Islas-Muñoz B; Infectious Disease Department, Instituto Nacional de Cancerología, Mexico City, Mexico.; Pokaż więcej
Corporate Authors:: Kaposi Sarcoma Study Group
Źródło:: PloS one [PLoS One] 2023 May 17; Vol. 18 (5), pp. e0280209. Date of Electronic Publication: 2023 May 17 (Print Publication: 2023).
Typ publikacji:: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Sarcoma, Kaposi*
HIV Infections*/complications
HIV Infections*/drug therapy
Herpesvirus 8, Human*
Anemia*/complications
Humans ; Valganciclovir/therapeutic use ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 45.

Tytuł:: Adoption is not associated with immunological and virological outcomes in children with perinatally acquired HIV infection in the Netherlands.
Autorzy:: Van Den Hof M; Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Smit C; HIV Monitoring Foundation, Amsterdam, the Netherlands.
Rossum AMCV; Department of Paediatrics, Sophia Children's Hospital, ErasmusMC, Rotterdam, the Netherlands.
Fraaij PLA; Department of Paediatrics, Sophia Children's Hospital, ErasmusMC, Rotterdam, the Netherlands.
Wolfs TFW; Department of Paediatrics, Wilhelmina Children's Hospital, Utrecht, the Netherlands.
Geelen SPM; Department of Paediatrics, Wilhelmina Children's Hospital, Utrecht, the Netherlands.
Scherpbier HJ; Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Schölvinck EH; Department of Paediatrics, Beatrix Children's Hospital, University Medical Centre Groningen, Groningen, the Netherlands.
Aerde KV; Department of Paediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, the Netherlands.
Reiss P; HIV Monitoring Foundation, Amsterdam, the Netherlands.; Department of Global Health, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
Wit FWNM; HIV Monitoring Foundation, Amsterdam, the Netherlands.; Department of Global Health, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
Pajkrt D; Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Pokaż więcej
Corporate Authors:: ATHENA cohort study group
Źródło:: PloS one [PLoS One] 2023 May 04; Vol. 18 (5), pp. e0284395. Date of Electronic Publication: 2023 May 04 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Child ; Prospective Studies ; Netherlands/epidemiology ; Antiretroviral Therapy, Highly Active ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 46.

Tytuł:: Assessing the impact of HIV support groups on antiretroviral therapy adherence and viral suppression in the African cohort study.
Autorzy:: Mbah P; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; HJF Medical Research International, Abuja, Nigeria.
Iroezindu M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA. .; HJF Medical Research International, Abuja, Nigeria. .
Esber AL; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA.
Dear N; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA.
Reed D; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA.
Adamu Y; U.S. Army Medical Research Directorate - Africa, Abuja, Nigeria.
Tiamiyu AB; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; HJF Medical Research International, Abuja, Nigeria.
Mohammed SS; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; HJF Medical Research International, Abuja, Nigeria.
Kibuuka H; Makerere University Walter Reed Project, Kampala, Uganda.
Maswai J; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; HJF Medical Research International, Kericho, Kenya.
Owuoth J; U.S. Army Medical Research Directorate - Africa, Kisumu, Kenya.; HJF Medical Research International, Kisumu, Kenya.
Bahemana E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; HJF Medical Research International, Mbeya, Tanzania.
Ake JA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Polyak CS; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA.
Crowell TA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD, USA.; Pokaż więcej
Corporate Authors:: AFRICOS Study Group
Źródło:: BMC infectious diseases [BMC Infect Dis] 2021 Jul 20; Vol. 21 (1), pp. 694. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Medication Adherence*
Self-Help Groups*
HIV Infections/*drug therapy
Adult ; Africa, Eastern ; Cohort Studies ; Female ; HIV Infections/psychology ; Humans ; Logistic Models ; Male ; Middle Aged ; Self Report ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 47.

Tytuł:: Late antiretroviral refills and condomless sex in a cohort of HIV-seropositive pregnant and postpartum Kenyan women.
Autorzy:: Eastment MC; Departments of Medicine, University of Washington, Seattle, Washington, United States of America.
Kinuthia J; Global Health, University of Washington, Seattle, Washington, United States of America.; Kenyatta National Hospital, Nairobi, Kenya.
Wang L; Global Health, University of Washington, Seattle, Washington, United States of America.
Wanje G; Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Wilson K; Global Health, University of Washington, Seattle, Washington, United States of America.
Kaggiah A; Kenyatta National Hospital, Nairobi, Kenya.
Simoni JM; Global Health, University of Washington, Seattle, Washington, United States of America.; Psychology, University of Washington, Seattle, Washington, United States of America.
Mandaliya K; Global Health, University of Washington, Seattle, Washington, United States of America.
Poole DN; Department of Geography, Dartmouth College, Hanover, New Hampshire, United States of America.
Richardson BA; Global Health, University of Washington, Seattle, Washington, United States of America.; Biostatistics, University of Washington, Seattle, Washington, United States of America.
Jaoko W; Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
John-Stewart G; Departments of Medicine, University of Washington, Seattle, Washington, United States of America.; Global Health, University of Washington, Seattle, Washington, United States of America.; Epidemiology, University of Washington, Seattle, Washington, United States of America.; Pediatrics, University of Washington, Seattle, Washington, United States of America.
McClelland RS; Departments of Medicine, University of Washington, Seattle, Washington, United States of America.; Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.; Epidemiology, University of Washington, Seattle, Washington, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Jul 19; Vol. 16 (7), pp. e0254767. Date of Electronic Publication: 2021 Jul 19 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Antiretroviral Therapy, Highly Active*
HIV Infections/*epidemiology
HIV Seropositivity/*epidemiology
Sexual Behavior/*psychology
Adolescent ; Adult ; Anti-Retroviral Agents/adverse effects ; Anti-Retroviral Agents/therapeutic use ; Female ; HIV Infections/drug therapy ; HIV Infections/transmission ; HIV Infections/virology ; Humans ; Intimate Partner Violence ; Kenya/epidemiology ; Longitudinal Studies ; Male ; Pregnancy ; Risk Factors ; Sexual Partners ; Unsafe Sex ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 48.

Tytuł:: Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania.
Autorzy:: Samizi FG; Mwananyamala Regional Referral Hospital, Dar es Salaam, Tanzania.
Panga OD; Geita Regional Health Management Team, Geita, Tanzania.
Mulugu SS; Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.
Gitige CG; Kibong'oto Infectious Diseases Hospital, Kilimanjaro, Tanzania.
Mmbaga EJ; Department of Epidemiology and Biostatistics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. .; Pokaż więcej
Źródło:: Journal of infection in developing countries [J Infect Dev Ctries] 2021 Jun 30; Vol. 15 (6), pp. 853-860. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji:: Journal Article
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Tuberculosis, Pulmonary*
HIV Infections/*drug therapy
Adolescent ; Adult ; Anti-HIV Agents/pharmacology ; Cohort Studies ; Drug Resistance, Viral ; Female ; HIV-1/drug effects ; Humans ; Male ; Prognosis ; Retrospective Studies ; Tanzania ; Treatment Failure ; Viral Load ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 49.

Tytuł:: HIV-1 Persistence in Children during Suppressive ART.
Autorzy:: Katusiime MG; HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, MD 21702, USA.
Van Zyl GU; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service Tygerberg, Cape Town 8000, South Africa.
Cotton MF; Department of Pediatrics and Child Health, Tygerberg Children's Hospital and Family Center for Research with Ubuntu, Stellenbosch University, Cape Town 7505, South Africa.
Kearney MF; HIV Dynamics and Replication Program, CCR, National Cancer Institute, Frederick, MD 21702, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2021 Jun 12; Vol. 13 (6). Date of Electronic Publication: 2021 Jun 12.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Anti-Retroviral Agents/*therapeutic use
Disease Reservoirs/*virology
HIV Infections/*virology
HIV-1/*pathogenicity
Child ; DNA, Viral/genetics ; Female ; HIV-1/genetics ; Humans ; Infectious Disease Transmission, Vertical ; Pregnancy ; Proviruses/genetics ; Viral Load ; Viremia/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 50.

Tytuł:: Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy.
Autorzy:: Galván-Díaz AL; Grupo de Microbiología Ambiental, Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia. .
Alzate JC; Unidad de Micología Médica y Experimental, Corporación para Investigaciones Biológicas-Universidad de Santander, Medellín, Colombia; Unidad de Investigación Clínica, Corporación para Investigaciones Biológicas, Medellín, ColombiaUnidad de Micología Médica y Experimental, Corporación para Investigaciones Biológicas-Universidad de Santander, Medellín, Colombia; Unidad de Investigación Clínica, Corporación para Investigaciones Biológicas, Medellín, Colombia. .
Villegas E; Unidad de Investigación Clínica, Corporación para Investigaciones Biológicas, Medellín, Colombia. .
Giraldo S; Unidad de Investigación Clínica, Corporación para Investigaciones Biológicas, Medellín, Colombia. .
Botero J; Unidad de Micología Médica y Experimental, Corporación para Investigaciones Biológicas-Universidad de Santander, Medellín, Colombia; Grupo de Parasitología, Facultad de Medicina; Corporación Académica para el Estudio de las Patologías Tropicales, Universidad de Antioquia, Medellín, Colombia. .
García-Montoya G; Centro Nacional de Secuenciación Genómica, Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia. .; Pokaż więcej
Transliterated Title:: Infección crónica por Cystoisospora belli en un paciente colombiano con HIV y cumplimiento deficiente de la terapia antirretroviral de gran actividad
Źródło:: Biomedica : revista del Instituto Nacional de Salud [Biomedica] 2021 May 31; Vol. 41 (Supl. 1), pp. 17-22. Date of Electronic Publication: 2021 May 31.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Acquired Immunodeficiency Syndrome*
Antiretroviral Therapy, Highly Active*
HIV Infections*/complications
HIV Infections*/drug therapy
Isosporiasis*/complications
Isosporiasis*/drug therapy
Colombia ; Diarrhea/etiology ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Antiretroviral Therapy, Highly Active"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język